Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment

Overexpression of G1-S regulators cyclin D1 or cyclin A is frequently observed in breast cancer and is also to result in ligand-independent activation of oestrogen receptor in vitro. This might therefore, provide a mechanism for failure of tamoxifen treatment. We examined by immunohistochemical stai...

Descripción completa

Detalles Bibliográficos
Autores principales: Michalides, R, van Tinteren, H, Balkenende, A, Vermorken, J B, Benraadt, J, Huldij, J, van Diest, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375223/
https://www.ncbi.nlm.nih.gov/pubmed/11875707
http://dx.doi.org/10.1038/sj.bjc.6600072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375223/
https://www.ncbi.nlm.nih.gov/pubmed/11875707
http://dx.doi.org/10.1038/sj.bjc.6600072

Ejemplares similares